EE267 Budget Impact Analysis of Introducing Fruquintinib for the Treatment of Previously Treated Metastatic Colorectal Cancer in the United States From the Payer Perspective
Autor: | Hernandez, LG, Paly, V, Li, S, Khanduri, P, Asfaw, AA, Zou, D |
---|---|
Zdroj: | In Value in Health June 2024 27(6) Supplement:S106-S106 |
Databáze: | ScienceDirect |
Externí odkaz: |